Sign Up Today and Learn More About LB Pharmaceuticals Stock
Invest in or calculate the value of your shares in LB Pharmaceuticals or other pre-IPO companies through EquityZen's platform.
LB Pharmaceuticals Stock (LBPH)
LB Pharmaceuticals specializes in developing a treatment for schizophrenia.
About LB Pharmaceuticals Stock
Founded
2015
Headquarters
New York, NY, US
Industries
Software, Artificial Intelligence, Data and Analytics
LB Pharmaceuticals Press Mentions
Stay in the know about the latest news on LB Pharmaceuticals
LB Pharmaceuticals Announces Publication in JAMA Psychiatry of Results from Phase 2 NOVA-1 Trial of LB-102 in Schizophrenia
biospace • Apr 24, 2026
Kailera makes history with record-breaking $625m IPO
pharmaceutical-technology • Apr 18, 2026
LB Pharmaceuticals Announces Presentation at 25th Annual Needham Virtual Healthcare Conference
biospace • Apr 10, 2026
LB Pharmaceuticals commences Phase III schizophrenia trial
clinicaltrialsarena • Mar 27, 2026
LB Pharmaceuticals Initiates Pivotal Phase 3 Trial (NOVA-2) for LB-102 in Patients with Schizophrenia
globenewswire • Mar 25, 2026
LB Pharmaceuticals Management
Leadership team at LB Pharmaceuticals
Co-founder & CEO
Zachary Prensky
Co-founder
Vince Grattan
Join now and verify your accreditation status to gain access to:
- LB Pharmaceuticals Current Valuation
- LB Pharmaceuticals Stock Price
- LB Pharmaceuticals Management
- Available deals in LB Pharmaceuticals and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- LB Pharmaceuticals Cap Table and Funding History by Share Class and Liquidity Preferences
- LB Pharmaceuticals Revenue and Financials
- LB Pharmaceuticals Highlights
- LB Pharmaceuticals Business Model
- LB Pharmaceuticals Risk Factors
- LB Pharmaceuticals Research Report from SACRA Research
Trading LB Pharmaceuticals Stock
How to invest in LB Pharmaceuticals stock?
Accredited investors can buy pre-IPO stock in companies like LB Pharmaceuticals through EquityZen funds. These investments are made available by existing LB Pharmaceuticals shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell LB Pharmaceuticals stock?
Shareholders can sell their LB Pharmaceuticals stock through EquityZen's private company marketplace. EquityZen's network includes over 450K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 53K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
